forstoringsglas

Search results

Vinge advises Advania’s shareholders in connection with the divestment to funds managed by Goldman Sachs

Vinge has advised the IT-provider company Advania with the divestment of a majority of the shares to funds managed by Goldman Sachs alongside management, VIA Equity and other reinvesting shareholders.
February 19, 2021

Vinge advises CELLINK in connection with the acquisition of Ginolis

Vinge has advised CELLINK AB (publ) in connection with the acquisition of all shares in Ginolis Oy. Ginolis conducts operations in relation to automated diagnostics and provides advanced robotic solutions to the medical- and diagnostics industries.
February 15, 2021

Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of FASAB Mark AB (“FASAB”).

FASAB is a local leading supplier of infrastructure services in the northern part of Skåne with a main focus on construction work on behalf of public purchasers via framework agreements with a yearly sales around SEK 300 million. The company’s management team will continue in their respective operational management roles and become shareholders of the Eleda group.
January 13, 2021

Vinge has advised Lone Star Fund and Stark Group in connection with the sale of the Stark Group to CVC Capital Partners.

Headquartered in Denmark, STARK Group is a leading B2B distributor of heavy building materials for the construction industry in the Nordics and Germany, with a focus on serving professional craftsmen. The business partners with 10,000 suppliers to serve c. 235,000 customers from more than 400 locations in Denmark (incl. Greenland), Sweden, Norway, Finland, and Germany. The transaction is subject to customary conditions and approvals and is expected to close in Q2 2021.
January 08, 2021

Vinge advises Industrifonden in connection with an investment in MinervaX

Vinge has advised Industrifonden in connection with its investment in MinervaX.
December 16, 2020

Vinge advised Investindustrial on its acquisition of Carl von Linnékliniken Group.

Carl von Linnékliniken Group is a leading fertility treatment clinic based in Uppsala offering various treatments such as IVF, IUI and gamete donation.
November 30, 2020

Vinge advises Main Capital in connection with the acquisition of PointSharp AB

PointSharp provides security solutions which enable enterprises to secure the login of their users to all their applications through e.g. multi-factor authentication, with a simplified user experience. PointSharp serves more than 220 customers globally.
November 13, 2020

Vinge advises GB HoldCo on its takeover bid for Gunnebo

Altor Fund V and Stena Adactum AB have, through the jointly controlled company GB HoldCo AB, announced a recommended cash offer to the shareholders of Gunnebo Aktiebolag. The offer values Gunnebo at approximately SEK 2.4 billion.
September 28, 2020

Vinge advises Litorina V in connection with the acquisition of Sushi Yama

Sushi Yama is a leading sushi restaurant chain with over 45 restaurants in Sweden.
August 11, 2020

Vinge has advised Axcel on its investment in AddPro

Axcel has signed an agreement to aquire a majority ownership stake in AddPro, a Swedish leading provider of IT and cloud services. AddPro’s current management team and founders will reinvest in the company alongside Axcel.
July 06, 2020

Vinge has advised Main Capital and Alfa eCare in connection with their strategic acquisition of Joliv

The Alfa eCare group is a recognized eHealth software company, providing solutions to both public and private healthcare providers throughout Sweden.
June 16, 2020

Vinge has advised Altair on its acquisition of assets from WRAP

The global technology company Altair has acquired the WRAP software business from Wrap International AB. The acquisition is a strategic complement to Altair’s portfolio.
May 12, 2020

Vinge advises Industrifonden in connection with financing

Vinge has advised Industrifonden in connection with Industrifonden leading a financing round in the amount of EUR 6 million in Elypta, a Swedish company which works with cancer diagnostics.
March 02, 2020

Vicore Pharma Holding acquires INIM Pharma

Vinge has advised the shareholders of INIM Pharma in connection with the sale of the company to Vicore Pharma Holding, which is listed on First North.
July 03, 2018
Previous